Learning Strategies for Improving Dual Task Performance in Multiple Sc
Learning Strategies for Improving Dual Task Performance in Multiple Sclerosis
What it found
We found no results in the registry or in papers.
This trial finished 5 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- StraDiMS implicit
- StraDiMs explicit
What it measured
Main measures
Dual task (STEP + substraction sevens)
day 2
Thinking and memoryDual task (STEP + substraction sevens)
day 4
Thinking and memoryDual task (STEP + phonetic word list generation)
day 2
Thinking and memoryDual task (STEP + phonetic word list generation)
day 4
Thinking and memoryDual task (STEP + Auditory vigilance)
day 2
Thinking and memoryDual task (STEP + Auditory vigilance)
day 4
Thinking and memoryDual Task (WALK + Subtraction sevens)
day 2
Thinking and memoryWalking and mobilityDual Task (WALK + Subtraction sevens)
day 4
Thinking and memoryWalking and mobilityDual Task (WALK + Word list generation (phonetic)
day 2
Thinking and memoryWalking and mobilityDual Task (WALK + Word list generation (phonetic)
day 4
Thinking and memoryWalking and mobilityDual Task (WALK + Auditory vigilance)
day 2
Thinking and memoryWalking and mobilityDual Task (WALK + Auditory vigilance)
day 4
Thinking and memoryWalking and mobilitylearning measure
Day 3
fNIRS measure (functional near-infrared spectroscopy)
day 4
Thinking and memory
Other measures (26)
Age
day 1
height
day 1
weight
day 1
educational level questionnaire
day 1
date of diagnosis questionnaire
day 1
type of MS questionnaire
day 1
EDSS
day 1
Disability progressionDigit span forwards visually
day 1
Brief Visuospatial Memory Test (BVMT)
day 1
Thinking and memory10/36 Spatial Recall test (SPART)
day 1
Who could take part
MS (type not specified) · 18 to 65 · EDSS 2.0 to 5.5
Show the full criteria
Inclusion criteria
* all participants: minimal cognitive function (MoCA ≥ 26) * Persons with MS: * Diagnosis of MS * EDSS 2.0 - 5.5 * No relapse within the past 30 days. * Able to walk minimally 6 minutes consecutively and to step over the stepping platform without aid.
Exclusion criteria
* Other medical conditions interfering with mobility. * Other neurological conditions. * Not able to understand instructions. * Major (unresolvable) problems with hearing or vision.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
This study is a randomized controlled study in which we aim to include 60 persons with Multiple Sclerosis and 30 healthy controls. Two different learning strategies, an explicit and an implicit one, will be compared on effects on dual task performance. Further, clinical profile associated with these effects, and brain activity measured by functional near-infrared spectroscopy during dual tasking will be investigated. To this end, the study will cover 4 days: Day 1: examine clinical profile; Day 2: baseline dual task measures; Day 3: experimental learning paradigm with subjects randomly assigned to either the implicit or the explicit learning condition. Day 4: delayed retention dual task and fNIRS measures.
Loading reviews and guidelines…
History
Started
Sept 2020
Main results due
Apr 2021
Finished
Apr 2021